SYRA HEALTH CORP. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised
SYRA HEALTH CORP. (SYRA) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised of 3.18 million shares for the 6-month period ending 2026-06-30, per its S-1 filed 2026-09-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised · last filed 2026-09-14
- SYRA HEALTH CORP. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2025-12-31 was 0.00 shares.
- SYRA HEALTH CORP. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2025-09-30 was 0.00 shares.
- SYRA HEALTH CORP. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2025-06-30 was 0.00 shares.
- SYRA HEALTH CORP. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2025-03-31 was 23.13K shares.
- SYRA HEALTH CORP. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2024 was 130.79K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 12 month |
|---|---|---|---|---|
| 2026-06-30 | 3.18M shares S-1 · filed 2026-09-14 | |||
| 2025-12-31 | 0.00 shares derived: S-1 12 month − 10-Q 9 month · filed 2026-09-14 | 0.00 shares derived: sum of 2 quarters · filed 2026-09-14 | 0.00 shares derived: sum of 3 quarters · filed 2026-09-14 | 23.13K shares S-1 · filed 2026-09-14 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-12 | 23.13K shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 23.13K shares 10-Q · filed 2025-08-12 | ||
| 2025-03-31 | 23.13K shares 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 130.79K shares 10-K · filed 2025-03-11 |